115
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Addressing the HIV-Related Needs of Substance Misusers in New York State: The Benefits and Barriers to Implementing a “One-Stop Shopping” Model

&
Pages 171-180 | Published online: 08 Feb 2011

REFERENCES

  • Astone, J. M., Strauss, S. M., Hagan, H., & Des Jarlais, D. C. (2004). Outpatient drug treatment program directors’ hepatitis-C related beliefs and their relationship to the provision of HCV services. The American Journal of Drug and Alcohol Abuse, 30, 783–797.
  • Astone, J. M., Strauss, S. M., Munoz-Plaza, C., Hagan, H., & Des Jarlais, D. C. (2005). Providing support to drug users infected with hepatitis C: The role of methadone maintenance treatment staff. Journal of Maintenance in the Addictions, 3, 33–46.
  • Astone-Twerell, J., Strauss, S. M., & Munoz-Plaza, C. (2006). Stigma2: Hepatitis C and drug abuse. HCV Advocate. Retrieved September 26, 2010, from http://www.hcvadvocate.org/hcsp/hcsp_pdf/Stigma.pdf
  • Bickel, W., & Vuchinich, R. (2000). Reframing health behavior change with behavioral economics. Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
  • Birkhead, G. S., Klein S. J., Candelas, A. R., O'Connell, D. A., Rothman, J. R., Feldman, I. S., (2007). Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach. International Journal on Drug Policy, 18, 417–425.
  • Breslin, K. T., & Malone, S. (2006). Maintaining the viability and safety of the methadone maintenance treatment program. Journal of Psychoactive Drugs, 38, 157–160.
  • Brown, L. S., Kritz, S., Goldsmith, R. J., Bini, E. J., Robinson, J., Alderson, D., (2007). Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs. Public Health Reports, 122, 441–451.
  • Canadian HIV/AIDS Legal Network. (1999). Injection drug use and HIV: Legal and ethical issues. Montreal, QC, Canada: Author.
  • Center for Substance Abuse Treatment. (1993). State methadone maintenance treatment guidelines (DHHS Publication No. SMA 93–1991). Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • Centers for Disease Control and Prevention. (2002). Linking HIV prevention services and substance abuse treatment programs. Retrieved September 26, 2010, from http://www.cdc.gov/idu/facts/HIVPrevServFin.pdf
  • Chitwood, D. D., Sanchez, J., Comerford, M., & McCoy, C. B. (2001). Primary preventive health care among injection drug users, other sustained drug users, and non-users. Substance Use & Misuse, 36, 807–824.
  • D'Aunno, T. A. (1997). Linking substance abuse treatment and primary care. In J. Egertson, D. M. Fox, & A. I. Leshner (Eds.), Treating drug abusers effectively (pp. 311–351). Malden, MA: Blackwell.
  • D'Aunno, T., Vaughn, T. E., & McElroy, P. (1999). An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior, 40, 175–192.
  • Day, C., Ross, J., & Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug and Alcohol Review, 22, 317–321.
  • Edlin, B. R., Seal, K. H., Lorvick, J., Kral, A. H., Ciccarone, D. H., Moore, L. D., (2001). Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? New England Journal of Medicine, 345, 211–215.
  • Fischer, B., Haydon, E., Rehm, J., Krajden, M., & Reimer, J. (2004). Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach—The case study of Canada. Journal of Urban Health, 81, 428–447.
  • Fleishman, J. A., Hsia, D. C., & Hellinger, F. J. (1994). Correlates of medical service utilization among people with HIV infection. Health Services Reports, 29, 527–548.
  • Friedmann, P. D., Alexander, J. A., Jin, L., & D'Aunno, T. A. (1999). On-site primary care and mental health services in outpatient drug abuse treatment units. The Journal of Behavioral Health Services & Research, 26, 80–94.
  • Friedmann, P. D., D'Aunno, T. A., Jin, L., & Alexander, J. A. (2000). Medical and psychosocial services in drug abuse treatment: Do stronger linkages promote client utilization? Health Services Research, 35, 443–465.
  • Goldman, W., McCulloch, J., & Sturm, R. (1998). Costs and use of mental health services before and after managed care. Health Affairs, 17, 40–52.
  • Gourevitch, M. N., Alcabes, P. Wasserman, W. C., & Arno, P. S. (1998). Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis. International Journal of Tuberculosis and Lung Disease, 2, 531–540.
  • Herbeck, D. M., Hser, Y.-I., & Teruya, C. (2008). Empirically supported substance abuse treatment approaches: A survey of treatment providers’ perspectives and practices. Addictive Behaviors, 33, 699–712.
  • Herman, M., & Gourevitch, M. N. (1997). Integrating primary care and methadone maintenance treatment: Implementation issues. Journal of Addictive Diseases, 16, 91–102.
  • Hoge, M. A., Huey, L. Y., & O'Connell, M. J. (2004). Best practices in behavioral health workforce education and training. Administration and Policy in Mental Health, 32, 91–106.
  • Karem-Hage, M., Nerenberg, L., & Brower, K. J. (2001). Modifying residents’ professional attitudes about substance abuse treatment and training. American Journal of Addictions, 10, 40–47.
  • Kelaher, M., & Jessop, D. J. (2006). The impact of loss of Medicaid on health service utilization among persons with HIV/AIDS in New York City. Health Policy, 76, 80–92.
  • Kleber, H. D., & Gawin, F. H. (1984). The spectrum of cocaine abuse and its treatment. Journal of Clinical Psychiatry, 45, 18–23.
  • Kraft, M. K., Rothbard, A. B., Hadley, T. R., McLellan, A. T., & Asch, D. A. (1997). Are supplementary services provided during methadone maintenance really cost effective? American Journal of Psychiatry, 154, 1214–1219.
  • Kwasnik, B. C., Moynihan R. T., & Royle, M. H. (1997). HIV mental health services integrated with medical care. In M. G. Winiarski (Ed.), HIV mental health for the 21st century (pp. 209–223). New York: New York University Press.
  • Larson, M. F., Samet, J. H., & McCarty, D. (1997). Managed care of substance abuse disorders: Implications for generalist physicians. Medical Clinics of North America, 81, 1053–1069.
  • Loughlin, A. M., Schwartz, R., & Strathdee, S. A. (2004). Prevalence and correlates of HCV infection among methadone maintenance attendees: Implications for HCV treatment. International Journal of Drug Policy, 15, 93–101.
  • McCoy, H. V., Messiah, S. E., & Zhao, W. (2002). Improving access to primary health care for chronic drug abusers: An innovative systematic intervention for providers. The Journal of Behavioral Health Services & Research, 29, 445–457.
  • McGovern, M. P., Fox, T. S., Xie, H., & Drake, R. E. (2004). A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. Journal of Substance Abuse Treatment, 26, 305–312.
  • McLaughlin, P. (2007). Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002–2005. Public Health Reports, 122(Suppl. 2), 48–51.
  • McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E., & O'Brien, C. P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953–1959.
  • McLellan, A. T., Hagan, T. A., Levine, M., Gould, F., Meyers, K., Bencivengo, M., (1998). Supplemental social services improve outcomes in public addiction treatment. Addiction, 93, 1489–1499.
  • Metsch, L. R., Pereyra, M., & Brewer, T. H. (2001). Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users. Journal of Substance Abuse, 13, 155–167.
  • Munoz-Plaza, C. E., Strauss, S. M., Astone, J. M., Des Jarlais, D. C., & Hagan, H. (2006). Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs. Journal of Psychoactive Drugs, 38, 233–241.
  • Patton, M. (1990). Qualitative evaluation and research methods. Newbury Park, CA: Sage.
  • Pillai, N. V., Kupprat, S. A., & Halkitis, P. N. (2009). Impact of service delivery model on health care access among HIV-positive women in New York City. AIDS Patient Care & STDs, 23(1), 51–58.
  • Rothman, J., Rudnick, D., Slifer, M., Agins, B., Heiner, K., & Birkhead, G. (2007). Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990–2002: A model for effective service delivery to a high risk population. Journal of Urban Health, 84, 226–242.
  • Samet, J. H., Friedmann, P., & Saitz, R. (2001). Benefits of linking primary medical care and substance abuse services. Archives of Internal Medicine, 161, 85–91.
  • Schoenbaum, M., Zhang, W., & Sturm, R. (1998). Costs and utilization of substance abuse care in a privately insured population under managed care. Psychiatric Services, 49, 1573–1578.
  • Selwyn, P. A. (1996). The impact of HIV infection on medical services in drug abuse treatment programs. Journal of Substance Abuse Treatment, 13, 397–410.
  • Selwyn, P. A., Budner, N. S., Wasserman, W. C., & Arno, P. S. (1993). Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports, 106, 492–500.
  • Stein, B., Reardon, E., & Sturm, R. (1999). Substance abuse service utilization under managed care: HMOs versus carve-out plans. Journal of Behavioral Health Services & Research, 26, 451–456.
  • Stephenson, J. (2001). Former addicts face barriers to treatment for HCV. Journal of the American Medical Association, 285, 1003–1005.
  • Sterk, C. E., Theall, K. P., & Elifson, K. W. (2002). Health care utilization among drug using and non-drug using women. Journal of Urban Health, 79, 586–599.
  • Strauss, S. M., Astone, J. M., Des Jarlais, D., & Hagan, H. (2004). A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug and Alcohol Dependence, 73, 227–236.
  • Strauss, S. M., Astone, J. M., Munoz-Plaza, C., Hagan, H., & Des Jarlais, D. C. (2005). Residential drug treatment programs as venues for HCV pharmacological treatment: Client and staff perspectives. Substance Use & Misuse, 40, 1811–1829.
  • Sturm, R. (1999). Tracking changes in behavioral health services: How have carve-outs changed care? Journal of Behavioral Health Services & Research, 26, 360–371.
  • Sturm, R., & McCulloch, J. (1998). Mental health and substance abuse benefits in carve-out plans and the Mental Health Parity Act of 1996. Journal of Health Care Finance, 24, 82–92.
  • Teitelbaum, M., Walker, A., Gabay, M., Gross, M., Mason, T., & Weitzman, E. (1992). Analysis of barriers to the delivery of integrated primary care services and substance abuse treatment: Case studies of nine linkage program projects. Washington, DC: Health Resources and Services Administration and ABT Associates.
  • Thomas, C. P., Wallack, S. S., Lee, S., McCarty, D., & Swift, R. (2003). Research to practice: Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment, 24, 1–11.
  • Tobias, C., Drainoni, M.-L., & McCree, J. (2000). Professional expert key informant report on HIV and substance abuse. Report of the Health & Disability Working Group, Boston University School of Public Health. Retrieved September 26, 2010, from http://www.hdwg.org/files/resources/HRSAprofessionalsurvey.pdf
  • Treloar, C. J., Hopwood, M. N., & Loveday, S. K. (2002). Hepatitis C-related discrimination in healthcare. Report of the Third Australasian Conference on Hepatitis C, Melbourne, March 2002. The Medical Journal of Australia, 177, 233–234.
  • Umbricht-Schneiter, A., Ginn, D. H., Pabst, K. M., & Begelow, G. E. (1994). Providing medical care to methadone clinic patients: Referral vs. on-site care. American Journal of Public Health, 84, 207–210.
  • van Olphen, J., & Freudenberg, N. (2004). Harlem service providers’ perceptions of the impact of municipal policies on their clients with substance use problems. Journal of Urban Health, 81, 222–231.
  • Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., & Lu, Y. (2001). Integrating primary medical care with addiction treatment: A randomized controlled trial. Journal of the American Medical Association, 286, 1715–1723.
  • Willenbring, M. (2005). Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS, 19(Suppl. 3): S227–S237.
  • Wright, E. R., & Shuff, I. M. (1995). Specifying the integration of mental health and primary health care services for persons with HIV/AIDS: The Indiana Integration of Care Project. Social Networks, 17, 319–340.
  • Zaller, N., Gillani, F. S., & Rich, J. D. (2007). A model of integrated primary care for HIV-positive patients with underlying substance use and mental health illness. AIDS Care, 19, 1128–1133.
  • Zickmund, S., Hillis, S. L., Barnett, M. J., Ippolito, L., & LaBrecque, D. R. (2004). Hepatitis C virus-infected patients report communication problems with physicians. Hepatology, 39, 999–1007.
  • Zickmund, S., Ho, E. Y., Masuda, M., Hipólito, L., & LaBrecque, D. R. (2003). “They treated me like a leper.” Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine, 18, 835–844.
  • Zweben, J. E. (2001). Hepatitis C: Education and counseling issues. Journal of Addictive Diseases, 20, 33–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.